XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

STOCKHOLDERS' DEFICIT | 9 Months Ended
--- | ---
Dec. 31, 2019
Equity [Abstract] |
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ DEFICIT COMMON STOCK During the nine months ended December 31, 2019, we issued 4,113,484 shares of Class A common stock in connection with the sale of 3,900,000 shares of our Class A common stock and the issuance of Class A common stock for preferred stock dividends. See Note - 8 Supplemental Cash Flow Disclosure. PREFERRED STOCK Cumulative dividends in arrears on preferred stock were $0.1 million as of December 31, 2019 and 2018. In January 2020, we paid the preferred stock dividends in arrears in the form of 124,622 shares of Class A common stock. TREASURY STOCK We have treasury stock, at a cost, consisting of 1,313,836 shares of Class A common stock at each of December 31, 2019 and March 31, 2019. CINEDIGM’S EQUITY INCENTIVE PLANS Stock Based Compensation Awards Awards issued under our 2000 Equity Incentive Plan (the "2000 Plan") may be in any of the following forms (or a combination thereof) (i) stock option awards; (ii) stock appreciation rights; (iii) stock or restricted stock or restricted stock units; or (iv) performance awards. The 2000 Plan provides for the granting of incentive stock options (“ISOs”) with exercise prices not less than the fair market value of our Class A Common Stock on the date of grant. ISOs granted to shareholders having more than 10% of the total combined voting power of the Company must have exercise prices of at least 110% of the fair market value of our Class A Common Stock on the date of grant. ISOs and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is subject to the continuous service of the participant. The exercise prices and vesting periods (if any) for non-statutory options are set at the discretion of our compensation committee. On November 1, 2017, upon the consummation of the transactions pursuant to the Stock Purchase Agreement, as a result of which there was a change of control of the Company, all stock options (incentive and non-statutory) and shares of restricted stock were vested immediately and the options became fully exercisable. In connection with the grants of stock options and shares of restricted stock under the 2000 Plan, we and the participants have executed stock option agreements and notices of restricted stock awards setting forth the terms of the grants. The 2000 Plan provided for the issuance of up to 2,380,000 shares of Class A Common Stock to employees, outside directors and consultants. As of December 31, 2019, there were 274,116 stock options outstanding in the Plan with weighted average exercise price of $15.00 and a weighted average contract life of 3.36 years. As of March 31, 2019, there were 300,315 shares outstanding in the Plan with weighted average exercise price of $14.87 and a weighted average contract life of 3.79 years. In August 2017, the Company adopted the 2017 Plan. The 2017 Plan replaced the 2000 Plan, and applies to employees and directors of, and consultants to, the Company. The 2017 Plan provided for the issuance of up to 2,108,270 shares of Class A common stock, in the form of various awards, including stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance awards and cash awards. The Compensation Committee of the Company’s Board of Directors (the “Board”) is authorized to administer the 2017 Plan and make grants thereunder. The approval of the 2017 Plan does not affect awards already granted under the 2000 Plan. On December 4, 2019, upon shareholder approval, the 2017 Plan was amended to increase the maximum number of shares of Class A common stock authorized for issuance thereunder from 2,108,270 shares to 4,098,270. An analysis of all options outstanding under the 2000 Plan as of December 31, 2019 is as follows:
As of December 31, 2019
Range of Prices |  | Options Outstanding |  | Weighted Average Remaining Life in Years |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value (In thousands)
$1.16 - $7.40 |  | 5,000 |  |  | 5.50 |  | $ | 7.40 |  |  | $ | — |
$13.70 - $24.40 |  | 261,616 |  |  | 3.37 |  | 14.71 |  |  | — |
$30.00 - $ 50.00 |  | 7,500 |  |  | 1.63 |  | 30.00 |  |  | — |
|  | 274,116 |  |  |  |  |  |  | $ | — |
An analysis of all options exercisable under the 2000 Plan as of December 31, 2019 is presented below:
| Options Exercisable |  | Weighted Average Remaining Life in Years |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value (In thousands)
As of December 31, 2019 | 2,251,725 |  | 3.36 |  | $15.00 |  | $ | — |
OPTIONS GRANTED OUTSIDE CINEDIGM’S EQUITY INCENTIVE PLAN In October 2013, we issued options outside of the Plan to 10 individuals who became employees as a result of a business combination. The employees received options to purchase an aggregate of 62,000 shares of our Class A Common Stock at an exercise price of $17.50 per share. The options are fully vested as of October 2017 and expire 10 years from the date of grant, if unexercised. As of December 31, 2019, 12,500 of such options remained outstanding. In December 2010, we issued options to purchase 450,000 shares of Class A Common Stock outside of the Plan as part of our Chief Executive Officer's initial employment agreement with the Company. Such options have exercise prices per share between $15.00 and $50.00, were vested as of December 2013 and will expire in December 2020. As of December 31, 2019, all such options remained outstanding. WARRANTS The following table presents information about outstanding warrants to purchase shares of our Class A common stock as of December 31, 2019. All of the outstanding warrants are fully vested and exercisable.
Recipient |  | Amount outstanding |  | Expiration |  | Exercise price per share
Strategic management service provider |  | 52,500 |  |  | July 2021 |  | $17.20 - $30.00
Warrants issued to Ronald L. Chez in connection with the Second Lien Loans |  | 206,768 |  |  | July 2023 |  | $1.34 - $1.57
Warrants issued in connection with Convertible Notes exchange transaction |  | 207,679 |  |  | December 2021 |  | $1.54
5-year Warrant issued to BEMG in connection with a term loan agreement |  | 1,400,000 |  |  | December 2022 |  | $1.80
The warrants issued in connection with the Second Lien Loans (See Note 5 - Notes Payable) to Ronald L. Chez, at the time a member of our Board of Directors, contain a cashless exercise provision and customary anti-dilution rights.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration